325 related articles for article (PubMed ID: 35597752)
1. Bispecific targeting of CD20 and CD19 increases polyfunctionality of chimeric antigen receptor T-cell products in B-cell malignancies.
Zurko JC; Xu H; Chaney K; Schneider D; Szabo A; Hari P; Johnson BD; Shah NN
Cytotherapy; 2022 Aug; 24(8):767-773. PubMed ID: 35597752
[TBL] [Abstract][Full Text] [Related]